The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients have with therapies from Alnylam and Novo Nordisk.
The Times of Israel on MSN1d
Israeli researchers use gene editing to eliminate 50% of head, neck tumors in miceTel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; ...
PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...
Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical ...
Turning silver nanoparticles into commercial products could create a faster pathway to new antimicrobials and cancer treatments.
University at Albany researchers at the RNA Institute are pioneering new methods for designing and assembling DNA ...
University at Albany researchers at the RNA Institute are pioneering new methods for designing and assembling DNA ...
Researchers at the RNA Institute at the University at Albany are pioneering new methods for designing and assembling DNA ...
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback